Page results
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using an insulin pump.
-
The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
The Adult Acute speech and language therapist (SLTs) work across a range of acute hospital specialities.
-
RNOH are pleased to launch a series of regular Health and Wellbeing Information and Support Sessions to support patients following a cancer diagnosis and also during/after treatment. These…
File results
-
FOI/2023/0220 - Internally produced patient information leaflets
-
FOI/2023/0218 - System for discharge letters, diagnostic reporting, digital dictation & bed management
-
FOI/2023/0217 - Integration platform(s) at the Trust
-
FOI/2023/0215 - British sign language procurement and communications
-
FOI/2023/0214 - Patients waiting over 78 weeks for elective care
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0208 - Patient trolleys/ stretchers
-
FOI/2023/0174 - Integration Engine (IE) within Trust's IT estate
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0175 - Treatment for Myelofibrosis